EdgarLookup

Inmune Bio, Inc. — All Filings

578 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 4 4/A 424B3 424B5 8-A12B 8-A12B/A 8-K 8-K/A CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP POS AM PRE 14A S-1 S-1/A S-3 S-3/A S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
S-8 REGISTRATION STATEMENT 0001213900-25-054427 Jun 16, 2025
S-8 REGISTRATION STATEMENT 0001213900-25-054428 Jun 16, 2025
8-K CURRENT REPORT 0001213900-25-053051 Jun 10, 2025
8-K CURRENT REPORT 0001213900-25-043270 May 14, 2025
DEFR14A REVISED DEFINITIVE PROXY STATEMENT 0001213900-25-041516 May 9, 2025
8-K CURRENT REPORT 0001213900-25-041082 May 8, 2025
10-Q QUARTERLY REPORT 0001213900-25-041072 May 8, 2025 Mar 31, 2025
8-K CURRENT REPORT 0001213900-25-040727 May 7, 2025
8-K CURRENT REPORT 0001213900-25-039733 May 5, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-035538 Apr 25, 2025
DEF 14A PROXY STATEMENT 0001213900-25-033742 Apr 21, 2025 May 28, 2025
8-K CURRENT REPORT 0001213900-25-032565 Apr 16, 2025
8-K CURRENT REPORT 0001213900-25-031590 Apr 14, 2025
SCHEDULE 13G/A 0000921895-25-001051 Apr 10, 2025
8-K CURRENT REPORT 0001213900-25-030129 Apr 9, 2025 Apr 3, 2025
8-K CURRENT REPORT 0001213900-25-027106 Apr 1, 2025
10-K ANNUAL REPORT 0001013762-25-003354 Mar 27, 2025 Dec 31, 2024
8-K CURRENT REPORT 0001013762-25-003401 Mar 27, 2025
8-K CURRENT REPORT 0001013762-25-001309 Mar 24, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-021719 Mar 7, 2025
8-K CURRENT REPORT 0001213900-25-020064 Mar 4, 2025
8-K CURRENT REPORT 0001213900-25-012870 Feb 12, 2025
8-K CURRENT REPORT 0001213900-25-011517 Feb 10, 2025
8-K CURRENT REPORT 0001213900-25-011733 Feb 10, 2025 Feb 6, 2025
8-K CURRENT REPORT 0001213900-25-007521 Jan 28, 2025
SCHEDULE 13G 0000921895-25-000109 Jan 15, 2025
8-A12B/A AMENDMENT NO. 4 TO FORM 8-A12B 0001213900-24-106924 Dec 9, 2024
4 0001213900-24-106920 Dec 9, 2024 Dec 5, 2024
4 0001213900-24-106913 Dec 9, 2024 Dec 5, 2024
4 0001213900-24-106916 Dec 9, 2024 Dec 5, 2024
4 0001213900-24-106914 Dec 9, 2024 Dec 5, 2024
4 0001213900-24-106915 Dec 9, 2024 Dec 5, 2024
8-K CURRENT REPORT 0001213900-24-106919 Dec 9, 2024 Dec 4, 2024
4 0001213900-24-106917 Dec 9, 2024 Dec 5, 2024
4 0001213900-24-106918 Dec 9, 2024 Dec 5, 2024
8-K CURRENT REPORT 0001213900-24-098380 Nov 14, 2024 Nov 13, 2024
8-K CURRENT REPORT 0001213900-24-097090 Nov 13, 2024
8-K CURRENT REPORT 0001213900-24-093531 Nov 1, 2024 Oct 31, 2024
10-Q QUARTERLY REPORT 0001213900-24-092861 Oct 31, 2024 Sep 30, 2024
8-K CURRENT REPORT 0001213900-24-091170 Oct 28, 2024
SC 13G 0000902664-24-005996 Oct 25, 2024
8-K CURRENT REPORT 0001213900-24-090766 Oct 25, 2024 Oct 24, 2024
8-K CURRENT REPORT 0001213900-24-090366 Oct 24, 2024
8-K CURRENT REPORT 0001213900-24-087245 Oct 11, 2024
4 0001213900-24-083348 Sep 30, 2024
8-K CURRENT REPORT 0001213900-24-082225 Sep 26, 2024
8-K CURRENT REPORT 0001213900-24-079445 Sep 17, 2024
8-K CURRENT REPORT 0001213900-24-078783 Sep 16, 2024 Sep 12, 2024
4 0001213900-24-079119 Sep 16, 2024 Sep 12, 2024
4 0001213900-24-079121 Sep 16, 2024 Sep 12, 2024